Drug intelligence / Profile preview

bacteriostatic sodium chloride 0.9% injection

Development stage
Phase 4
Lead developer
Pfizer
Modality
Small Molecules
Administration
Intravenous, Intramuscular, Subcutaneous
01

Overview

Bacteriostatic normal saline is a sterile, nonpyrogenic, isotonic solution of 0.9% sodium chloride in water for injection, supplemented with an antimicrobial preservative, typically 0.9% (9 mg/mL) benzyl alcohol. It is primarily utilized as a sterile vehicle or diluent for the reconstitution and dilution of compatible drugs intended for parenteral administration. The presence of the bacteriostatic agent allows for multiple entries into the vial, facilitating the withdrawal of multiple doses from a single container. However, its use is strictly contraindicated in neonates due to the risk of "gasping syndrome" associated with benzyl alcohol toxicity, and it must not be used for epidural or intrathecal anesthesia procedures.

Other names
bacteriostatic normal salinebacteriostatic salinebacteriostatic 0.9% sodium chloride

Beyond the preview

Go deeper on bacteriostatic sodium chloride 0.9% injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on bacteriostatic sodium chloride 0.9% injection.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call